Abstract Background Recent investigations suggest that activation of coagulation and fibrinolysis occurs in patients with ulcerative colitis (UC).
Introduction

In patients with inflammatory bowel disease (IBD), mucosal and systemic hypercoagulation has been documented by several investigators (1-6). The increased risk of thromboembolic complications in patients with ulcerative colitis (UC) is well recognized
. Based on these observations, heparin was used to treat or prevent thromboembolic events in UC patients (7) (8) (9) (10) (11) . However, the efficacy of anticoagulant therapy, such as heparin, in UC patients remains controversial (7) (8) (9) (10) (11) (12) . Normalization of markers of the coagulation system has been documented during treatment, which suggests that the observed abnormalities are secondary to the disease state (5, 13) . There have been no complete studies on the hypercoagulable state in UC on the total coagulation system, although there have been many reports on a part of the system (1) (2) (3) (4) (5) (6) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) . Therefore, the first aim of this study was to compare active with inactive UC in relation to the hypercoagulable tendency in the total coagulation system. (33, 34) . In most patients with IC, the disease requires no specific therapy such as anticoagulant therapy. However, there are no reports concerning the coagulation state in patients with IC. Thus, the second aim of 
Reversible vascular occlusion that affects the colon is called ischemic colitis (IC). The primary cause of the condition of IC is impaired perfusion, while the inflammatory reaction is secondary
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Results
The mechanism of hemostasis consists of two steps: thrombus formation and coagulation. The first step of thrombus formation occurs as a result of vascular injury and aids in the initiation of the coagulation system.
The first step of thrombus formation (Table 2)
The first step of thrombus formation inclusive of platelet count, vWF and fibrinogen were shown Table 2 .
Platelet counts in active UC patients were significantly higher than in inactive UC patients. The mean serum vWF level was significantly elevated in active UC and IC patients
T a b l e 2 . P l a s ma L e v e l s o f t h e P a r a me t e r s a b o u t t h e F i r s t S t e p o f T h r o mb u s F o r ma t i o n
compared to inactive UC patients.
The coagulation system (Table 3)
The coagulation system is consists of five steps.
1) The extrinsic pathway
There was no significant difference in PT among active UC, IC and inactive UC patients. The factor VIIa level in active UC and IC patients was higher than that in inactive UC patients.
2) The intrinsic pathway
There was no significant difference in APTT among the three groups of patients. The factor XIIa level in active UC and IC patients was higher than that in inactive UC patients. The mean level of factor XIa was significantly higher in active UC and IC patients than that in inactive UC patients.
3) The common pathway
There was no significant difference in TT among the three groups of patients. Factor IXa, VIIIa and Va levels were significantly elevated in active UC and IC patients compared to those in inactive UC patients. Factor Xa and AT-III levels in active UC patients were significantly higher than those in inactive UC and IC patients.
4) The thrombin-generating system
Factor IIa and protein C levels in active UC patients were significantly higher than those in IC and inactive UC patients. There was no significant difference in protein S level among the three groups of patients. 
5) The fibrinolysis system
Discussion
In the present study we found that the parameters of the total coagulation-fibrinolysis system were higher in active UC and IC patients than in inactive UC patients, and that the parameters of the total coagulation-fibrinolysis system in inactive UC patients were all within the normal range.
The incidences of thromboembolic events in patients with IBD have been reported to be 1%-8% (35) (36) (37) (38) (39) (40) (37) . (2, (20) (21) (22) (23) (24) (25) . Our results revealed that factor IXa, Xa, Va, VIIIa and AT-III levels were higher in active UC and IC than inactive UC, and suggested that common pathways were initiated by extrinsic and intrinsic pathways. (2, 17, 26) . On the other hand, the present results suggested that there were no cases of hereditary thrombophilia in our study, since AT-III, protein C and protein S were within the normal range among all patients. It is known that the factor V Leiden mutation that contributes to resistance to activated protein C is rare in the Japanese population (48, 49) . F1+2 and TAT have been found to be reliable markers of thrombin generation. The present data also showed that mean F1+2 and TAT were significantly higher in active UC and IC than inactive UC, and suggested that thrombin generation might be an early event in UC and IC. It is well known that F1+2 and TAT are useful markers of the activation of blood coagulation in IBD (4) (5) (6) (27) (28) (29) (30) . Moreover, the activation of F1+2 and TAT is a risk factor for DVT and PE in IBD (48) . (4, 31, 32 (52) . Thus, disturbances in the mechanisms of coagulation will presumably be reflected in the products of both coagulation and fibrinolysis (5) .
Disease activity is a probable risk factor for thromboembolism (40, 43). It is noteworthy however that one-third of thromboembolic complications occur in patients with quiescent disease (40). Therefore, we studied the hypercoagulability in active UC patients and compared it to that in inactive UC patients and IC patients with reversible ischemia requiring no specific therapies. The hypercoagulable state in active UC patients is closely related to abnormal platelet function resulting in a high probability of microvascular thrombosis and microcirculatory dysfunction (14-16). On the other hand, vWF is a large glycoprotein that circulates in human plasma and is deposited in the vascular subendothelium. In response to endothelial injury, vWF also mediates platelet to platelet interactions and platelet adhesion to the subendothelium (44). We found that the median serum vWF concentration was significantly higher in active UC and IC patients than in inactive UC patients. The elevated vWF value in UC patients could be caused by either vascular injury occurring secondary to bowel inflammation or an acute phase response to endothelial cell stimulation by mediators released during the inflammatory process (17-19). The coagulation system can be divided into extrinsic and intrinsic pathways (1). The intrinsic pathway is initiated when blood is exposed to a negatively charged surface, which activates factor XII (45, 46). Activation of factors XIIa and XIa have been reported in <10% of patients with UC (20, 21). We found that factor XIIa and XIa levels in active UC and IC patients were higher than those in inactive UC patients, and we considered that bowel inflammation might expose a negatively charged subluminal surface of inflamed vessels to peripheral blood. The extrinsic pathway is initiated by tissue damage that exposes the tissue factor (TF)-factor VII complex. It is thought that high factor VIIa activity is associated with an increased risk of ischemic myocardial events in man subjects over 40 years of age (18, 47). Hudson et al reported that the mean factor VIIa level was significantly higher in UC patients than in normal subjects (3). We also found that the factor VIIa level in active UC and IC patients was higher than that in inactive UC patients, and considered that increased concentrations of factor VIIa might complicate microvascular damage and inflammation in the intestinal wall by augmenting the focal fibrin deposition on the luminal surface of inflamed vessels. Several investigators have reported that factor IXa, Xa, Va and VIIIa levels were elevated, while the AT-III level was decreased in active UC
Deficiencies of AT-III, protein C and protein S are wellrecognized causes of thrombotic disease in UC patients
D-D is a marker of hyperfibrinolysis, and high D-D levels have been reported in IBD
The present active UC and IC patients showed similar results for the total coagulation-fibrinolysis system, and also they recovered without steroid or anticoagulant therapy. The parameters of the total coagulation-fibrinolysis system, except PT, APTT and TT, were higher in active UC and IC patients than in inactive UC patients, although the difference did not always reach statistical significance. The interaction between thrombosis and inflammation is becoming increasingly recognized (1) (2) (3) (36) (37) (38) (39) (40) (41) (42) (43) (13, 14, 17, 21-23, 25-27, 30-32, 37-43 
